On December 29, 2023, Moderna (MRNA) had a market capitalization of $39.3B, based on 395M shares at a price of $99.45.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2023 | $99.45 | 118,510,000 | 395,000,000 | $39,282,750,000.00 |
November 2023 | $77.70 | 90,980,000 | 395,000,000 | $30,691,500,000.00 |
October 2023 | $75.96 | 89,020,000 | 395,000,000 | $30,004,200,000.00 |
September 2023 | $103.29 | 74,200,000 | 381,000,000 | $39,353,490,000.00 |
August 2023 | $113.07 | 102,670,000 | 381,000,000 | $43,079,670,000.00 |
July 2023 | $117.66 | 64,970,000 | 381,000,000 | $44,828,460,000.00 |
June 2023 | $121.50 | 60,080,000 | 381,000,000 | $46,291,500,000.00 |
May 2023 | $127.71 | 74,860,000 | 381,000,000 | $48,657,510,000.00 |
April 2023 | $132.89 | 69,930,000 | 381,000,000 | $50,631,090,000.00 |
March 2023 | $153.58 | 73,720,000 | 405,000,000 | $62,199,900,000.00 |
February 2023 | $138.81 | 72,070,000 | 405,000,000 | $56,218,050,000.00 |
January 2023 | $176.06 | 74,990,000 | 405,000,000 | $71,304,300,000.00 |
December 2022 | $179.62 | 153,650,000 | 405,000,000 | $72,746,100,000.00 |
November 2022 | $175.91 | 90,270,000 | 405,000,000 | $71,243,550,000.00 |
October 2022 | $150.33 | 104,680,000 | 405,000,000 | $60,883,650,000.00 |
September 2022 | $118.25 | 110,260,000 | 412,000,000 | $48,719,000,000.00 |
August 2022 | $132.27 | 109,750,000 | 412,000,000 | $54,495,240,000.00 |
July 2022 | $164.09 | 89,720,000 | 412,000,000 | $67,605,080,000.00 |
June 2022 | $142.85 | 114,320,000 | 419,000,000 | $59,854,150,000.00 |
May 2022 | $145.33 | 145,010,000 | 419,000,000 | $60,893,270,000.00 |
April 2022 | $134.41 | 109,540,000 | 419,000,000 | $56,317,790,000.00 |
March 2022 | $172.26 | 187,010,000 | 426,000,000 | $73,382,760,000.00 |
February 2022 | $153.60 | 141,520,000 | 426,000,000 | $65,433,600,000.00 |
January 2022 | $169.33 | 199,840,000 | 426,000,000 | $72,134,580,000.00 |
December 2021 | $253.98 | 246,490,000 | 431,000,000 | $109,465,380,000.00 |
